Themis Medicare Ltd

Themis Medicare Capital Structure Change

Themis Medicare Ltd withdrew its proposed preferential issue of 45,95,795 warrants. The company secured working capital through alternative means, and no adverse impact is expected.

Themis Medicare Dividend

Themis Medicare fixed the record date as September 23, 2026, for its final dividend FY 2025-26, pending AGM approval on September 30, 2026. No dividend per-share amount is stated.

Themis Medicare Annual General Meeting

Themis Medicare Limited has issued the notice for its upcoming Annual General Meeting scheduled for September 30, 2026. Shareholders will consider resolutions including dividend declaration.

Themis Medicare Annual Report

Themis Medicare Limited has filed its Annual Report for the financial year 2025-26, along with the notice for its 56th Annual General Meeting.

Themis Medicare Price Movement Clarification

Themis Medicare Limited has clarified to the exchange that there is no pending or delayed material information regarding the recent increase in trading volume.

Themis Medicare Management Change

Themis Medicare has appointed Suresh Savaliya as Company Secretary and Compliance Officer, replacing Nagraj Mogoveera, who transitioned to another role within the company.

Themis Medicare Investor Presentation: Key Takeaways

Themis Medicare Q1 FY27 revenue hit ₹86.96 Cr with 28.3% PAT margin, significantly boosted by one-off gains of ₹92.95 Cr from share sales.

Themis Medicare Other Announcement

Themis Medicare Ltd has updated its list of authorized persons responsible for determining the materiality of information and disclosures under SEBI Regulation 30(5).

Themis Medicare Q1 FY27 Results: Turns Profitable, Net Profit ₹24.6 Cr

Themis Medicare Ltd reported revenue from operations of ₹87 Cr (-10.9% YoY) and net profit of ₹24.6 Cr for Q1 FY27.

Key figure

Net profit ₹24.6 Cr

Themis Medicare Board Meeting Date

Themis Medicare Ltd has scheduled a board meeting for August 13, 2026, to approve the standalone and consolidated financial results for the quarter ending June 30, 2026.

Themis Medicare Share Pledge

Vividhmargi Investments Private Limited, a promoter of Themis Medicare Limited, created a pledge of 30,00,000 equity shares. The pledge represents 3.26% of the company's total share capital.

Themis Medicare Other Announcement

Themis Medicare Ltd filed its quarterly shareholding pattern for the period ended June 30, 2026. The report includes explanatory notes regarding prior internal promoter group restructuring.

Themis Medicare Other Announcement

Themis Medicare Ltd filed its quarterly shareholding pattern for the period ended June 2026, noting internal promoter group entity restructuring and shareholding consolidation.

Themis Medicare Share Pledge

Promoter Vividhmargi Trust created a pledge over 2.53 crore shares of Themis Medicare Ltd as collateral for a ₹135 Crore loan facility.

Value

₹135.0 Cr

Themis Medicare Share Pledge

Vividhmargi Investments Private Limited released a pledge on 15,00,000 equity shares of Themis Medicare. This reduces the promoter group's total encumbered stake to nil.

Themis Medicare Share Pledge

Pharmaceutical Business Group (India) Limited reported an indirect encumbrance on 47.02% of Gujarat Themis Biosyn's equity. This follows a pledge creation by Vividhmargi Investments.